Programme
THURSDAY, 14 NOVEMBER 2019 |
|
| 9:00 | Patient advocacy session: The do’s and don’ts of complementary medicine (Chairs: Anna Cabanes, US and Renate Haidinger, DE) • Complementary medicine: what helps and what doesn’t (Maria João Cardoso, PT) • New drugs, different side effect: can complementary medicine help? (Christoph Thomssen, DE) • The danger of being lost between two worlds (Renate Haidinger, DE) • Panel discussion and Q&A (Moderated by the chairs) |
| 9:00 | Sponsored satellite symposium 1 (details are available HERE) |
| 10:30 | Coffee break |
| 11:00 | Patient advocacy session: Having difficult conversations: Empowering patients and their families with tools and strategies of communication at end of life (Chairs: Ranjit Kaur, MY, Catherine Priestley, UK and Shawna Rich-Ginsberg, CA) • Accessing palliative care - Why the resistance? (Matti S. Aapro, CH) • Navigating end of life conversations with family members and children (Luzia Travado, PT) • Supporting decision making and advance care planning - A case study of two patients (2 ABC patients) • Bereavement Support in the MBC Community (Shawna Rich-Ginsberg, CA) • Discussion |
| 11:00 | Sponsored satellite symposium 2 (details are available HERE) |
| 12:30 | Lunch |
| 13:30 | Opening session (Chairs: Fatima Cardoso, PT and Larry Norton, US) • Welcome to Lisbon (Prof. Marcelo Rebelo de Sousa, President of the Portuguese Republic) • Keynote lecture: a good doctor treats the disease; a great doctor treats the patient with the disease. How not to lose the joy of living in the fear of dying (Claire Myerson, UK) |
| 14:20 | ABC5 Award and lecture (Chair: Larry Norton, US) • Making a difference for advanced breast cancer patients (Fatima Cardoso, PT) |
| 14:50 | Meaningful clinical benefit: How to define, evaluate and communicate (Chairs: Bella Kaufman, IL and Shirley A. Mertz, US) • Applying the ESMO-MBCS to ABC systemic therapies (Shani Paluch-Shimon, IL) • Optimal endpoints for ABC clinical trials: can we aim for more? (Nadia Harbeck, DE) • Optimizing clinical trial designs in ABC: reaching relevant clinical benefit (Eric P. Winer, US) • Estimating and communicating survival times for each ABC patient (Belinda E. Kiely, AU) • The role of big data and real-world data (George W. Sledge, US) • Panel Discussion (All) |
| 16:25 | Coffee break |
| 16:55 | Discussing the hardest issues (Chairs: Anna Cabanes, US and Karen Gelmon, CA) • When to stop and who decides? (Gabriella Pravettoni, IT) • Suicide and assisted suicide in ABC patients (Uwe Güth, CH) • Optimal end of life care (Carla Ripamonti, IT) • Panel discussion: how to support the terminally and family (All) |
| 18:00 | Patient advocacy session: When cancer becomes visible - living with skin metastases from breast cancer (Chairs: Bertha Aguilar Lopez, MX, Maria João Cardoso, PT and Gertrude Nakigudde, UG) • Skin Metastases: the extension of the problem (Maria -Joao Cardoso, PT) • Do skin metastases have a different biology? (Joana Ribeiro, PT) • Skin directed therapy: electrochemotherapy, is it a real option? (Giuseppe Curigliano, IT) • Skin directed therapy: radiotherapy and topical therapy (Birgitte V. Offersen, DK) • Taking care of malignant wound – what should be considered? (Christine B. Boers-Doets, NL) • Panel discussion and Q & A (Moderated by the chairs) |
| 18:00 | Sponsored satellite symposium 3 (details are available HERE) |
| 19:30 | Welcome cocktail |
FRIDAY, 15 NOVEMBER 2019 |
|
| 7:30 | Sponsored satellite symposium (TBC) |
| 8:30 | Understanding and applying biology knowledge (Chair: Gertrude Nakigudde, UG and Daniel A. Vorobiof, US) • Next generation sequencing for clinical decisions: friend or foe (Fabrice André, FR) • Is lobular ABC a separate entity? (Sabine Linn, NL) • De novo vs. recurrent ABC (Prudence A. Francis, AU) • Biomarkers for new approaches: what have we been doing wrong? (Aleix Prat, ES) • Discussion |
| 9:40 | Best abstract presentations (Chairs: Alberto Costa, IT and Renate Haidinger, DE) • Femama strategies to ensure HER2+ breast cancer treatments in Brazil (Maria Caleffi, BR) • T-DM1 efficacy and activity in HER2-positive metastatic breast cancer patients progressing after frontline taxane plus pertuzumab and trastuzumab: an italian multicenter observational study of the Gruppo Italiano Mammella (GIM) study group (Benedetta Conte, IT) • A targeted survey of Belong.Life advanced breast cancer (ABC) patient’s (PTS), focusing on patient’s reported outcomes (PROS), real world evidence (RWE) and insights in reducing the burden of financial toxicity (FT) (Daniel A. Vorobiof, US) |
| 10:15 | Coffee break |
| 10:35 | Latest news: Triple negative ABC (Chairs: Kirsten Pilatti, AU and Binghe Xu, CN) • Standards of care and optimal options (Hope S. Rugo, US) • New targets, new drugs (Andrew Tutt, UK) • Biology and resistance (Giuseppe Curigliano, IT) • Discussion |
| 11:30 | Managing side effects and difficult symptoms (Chairs: Jonas Bergh, SE and Renate Haidinger, DE) • Overcoming global hurdles in pain management: from morphine shortage to opioid abuse (Matti S. Aapro, CH) • Gynecological and sexual symptoms: the silent suffering (Christoph Thomssen, DE) • Fatigue and cachexia: from biology to solutions (Carlos H. Barrios, BR) • Discussion |
| 12:30 | Lunch and poster session - Documentary film: The Champions |
| 13:30 | Latest news: Luminal ABC (Chairs: Bertha Aguilar Lopez, MX and Nagi S. El Saghir, LB) • Standards of care and optimal options (Joseph Gligorov, FR) • New targets, new drugs (Peter Schmid, UK) • Biology and resistance (Carsten Denkert, DE) • Discussion |
| 14:25 | Specific sites of metastases (Chairs: Alexandru Eniu, RO and Sung-Bae Kim, KR) • Update on systemic therapy of brain metastases (Nancy U. Lin, US) • Leptomeningeal disease (Laura Biganzoli, IT) • The role of new RT techniques for metastases treatment (Birgitte V. Offersen, DK) • Discussion |
| 15:35 | Coffee break |
| 16:00 | Latest news: HER2+ ABC (Chairs: Ranjit Kaur, MY and Silvia Neciosup, PE) • Standards of care and optimal options (Lisa A. Carey, US) • New targets, new drugs (Javier Cortés, ES) • Biology and resistance (Frédérique Penault-Llorca, FR) • Discussion |
| 17:00 | Improving monitoring of efficacy and toxicity (Chairs: Olivia Pagani, CH and Shawna Rich-Ginsberg, CA) • Implementing PROMs in clinical research and clinical practice (Lesley Fallowfield, UK) • Optimal imaging techniques for bone only disease Frédéric (E. Lecouvet, BE) • The role of liquid biopsies (Paul Mainwaring, AU) • Discussion |
| 18:00 | Patient advocacy session: Improving your communication skills: the floor is yours (Chairs: Shirley A. Mertz, US and Kirsten Pilatti, AU) • Doctors need to believe in miracles too: ensuring you understand therapeutic aims of treatment recommendations (Lesley Fallowfield, UK) • Building communication skills in health professionals – the role that advocates can play (Fran Boyle, AU) • The power of storytelling in advocating for change - 3 case studies (Shirley A. Mertz, US and Kirsten Pilatti, AU) • Q&A session |
| 18:00 | Sponsored satellite symposium 5 (details are available HERE) |
SATURDAY, 16 NOVEMBER 2019 |
|
| 8:30 | Consensus session (part I) (ABC5 chairs, Scientific Committee Members and Panellists) |
| 10:30 | Coffee break |
| 11:00 | Report from ABC Patient Advocacy Committee (Shirley A. Mertz, US) |
| 11:15 | Consensus session (part II) (ABC5 chairs, Scientific Committee Members and Panellists) |
| 12:45 | Close |
A/V RECORDING DURING THE CONFERENCE IS PROHIBITED
ABC Global Alliance
|
|
|
|
ABC5 will be followed by the ABC Global Alliance meeting: |
SATURDAY, 16 NOVEMBER 2019 |
|
| Meeting room 3A/3B | |
| 14:30 | Welcome, meeting overview and introduction (Fatima Cardoso, PT) |
| 14:45 | The ABC Global Alliance: overview of the initiatives implemented (Fatima Cardoso, PT) |
| 15:10 | Discussion and suggestions for 2020 (Moderators: Ranjit Kaur, MY and Kirsten Pilatti, AU) |
| 15:45 | Introduction to the Sunday workshops (Fatima Cardoso, PT and Lesley Fallowfield, UK) |
| 16:00 | Coffee break |
| 16:30 | Executive Committee 2019-2021 Election (Fatima Cardoso, PT - Renate Haidinger, DE and Shirley A. Mertz, US) |
SUNDAY, 17 NOVEMBER 2019 |
|
| Meeting room 3A/3B | |
| 8:30 | Welcome and introduction (Fatima Cardoso, PT and Lesley Fallowfield, UK) |
| 8:40 | Workshop (4 groups) (Moderators: Fran Boyle, AU - Lesley Fallowfield, UK - Belinda Kiely, AU and Luzia Travado, PT) |
| 10:30 | Coffee break |
| 12:15 | Report back from Groups |
| 13:00 | Meeting close (Fatima Cardoso, PT) |
WORKSHOP AIM
The Sunday workshops will be dedicated to discuss important communication issues related to ABC.
Four main questions will be asked to all participants:
1. What I wish I’d known about ABC/MBC before my diagnosis
2. Things I still don’t understand about ABC and treatment options
3. Things my Health Care Professionals did that a) helped b) didn’t help
4. Things friends and family could do to help when you have ABC
In order to allow participant to express their opinions, the audience will be divided in smaller groups and each group will discuss the same questions.
Answers will be collected, discussed, taking into account geographical and cultural differences, and conclusions and future actions will be agreed upon.
For further information about the ABC Global Alliance, please contact
Roberta Ventura, abcglobalalliance@eso.net, ph +41 91 820 0957